bioAffinity Technologies vs OmniAb
BIAF and OABI side by side, both in engineering, accounting, research, management, and related services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BIAF and OABI compare
OmniAb is the larger company, worth 47 times as much as bioAffinity Technologies ($737M against $15.6M).
OmniAb grew revenue faster over the last twelve months (90.6% versus −23.2% for bioAffinity Technologies).
OmniAb keeps more of each dollar of sales as profit, with a net margin of −108% compared with −257% at bioAffinity Technologies.
OmniAb scores higher on the StockData Score (9 against 5 for bioAffinity Technologies), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BIAF | OABI |
|---|---|---|
| Size and price | ||
| Market cap | $15.6M | $737M |
| Share price | $1.93 | $5.05 |
| Change, 1 year | −93.0% | 224% |
| Change, 5 years | – | −49.5% |
| Beta (5Y) | – | 1.68 |
| Employees | 57 | 107 |
| StockData Score | ||
| Total score | 5 | 9 (better) |
| Valuation score | 3 (better) | 1 |
| Growth score | 0 | 1 (better) |
| Performance score | 0 | 1 (better) |
| Health score | 2 | 6 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 2.6× (better) | 18.3× |
| P/B | 4.1× | 3.0× (better) |
| P/FCF | – | 309× |
| FCF yield | −73.9% | 0.32% (better) |
| Fair value | $6.61 | $3.71 |
| Margin of safety | 70.8% (better) | −36.2% |
| Growth | ||
| Revenue growth (TTM) | −23.2% | 90.6% (better) |
| Profitability | ||
| Operating margin | −210% | −116% (better) |
| Net margin | −257% | −108% (better) |
| FCF margin | −196% | 5.9% (better) |
| Return on equity | −1860% | −16.5% (better) |
| Return on invested capital | – | −18.3% |
| Financial health | ||
| Debt / equity | 0.01 (better) | 0.00 |
| Interest coverage | −276.1× | – |
| Current ratio | 1.44 | 4.21 (better) |
| Altman Z-score | −15.85 | 9.48 (better) |
| Piotroski F-score | 2 | 2 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 1.6% | 42.4% |
| Held by insiders | 59.3% | 5.9% |
| Insider net buying, 12 months | – | −$283K |
Go deeper
- BIAF stock overview
- BIAF income statement
- BIAF valuation and score
- OABI stock overview
- OABI income statement
- OABI valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.